Actinium Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNM and other ETFs, options, and stocks.About ATNM
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients.
CEOSandesh Seth
CEOSandesh Seth
Employees49
Employees49
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2000
Founded2000
Employees49
Employees49
ATNM Key Statistics
Market cap207.83M
Market cap207.83M
Price-Earnings ratio-3.84
Price-Earnings ratio-3.84
Dividend yield—
Dividend yield—
Average volume299.17K
Average volume299.17K
High today$7.31
High today$7.31
Low today$6.88
Low today$6.88
Open price$6.95
Open price$6.95
Volume152.63K
Volume152.63K
52 Week high$9.86
52 Week high$9.86
52 Week low$4.00
52 Week low$4.00
ATNM News
TipRanks 6d
Actinium Pharmaceuticals' Iomab-B improves survival in refractory AML - TipRanks.com - TipRanksActinium Pharmaceuticals announced that results from the Phase 3 SIERRA trial of Iomab-B were presented in an oral presentation at the 50th Annual European Bone...